Efficacy of rituximab therapy in children with nephrotic syndrome: a 10-year experience from an Iranian pediatric hospital
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2431
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Efficacy of rituximab therapy in children with nephrotic syndrome: a 10-year experience from an Iranian pediatric hospital ; volume:22 ; number:1 ; day:12 ; month:1 ; year:2022 ; pages:1-9 ; date:12.2022
BMC pediatrics ; 22, Heft 1 (12.1.2022), 1-9, 12.2022
- Urheber
-
Bazargani, Behnaz
Noparast, Zahra
Khedmat, Leila
Fahimi, Daryoosh
Esfahani, Seyed Taher
Moghtaderi, Mastaneh
Abbasi, Arash
Afshin, Azadeh
Mojtahedi, Sayed Yousef
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12887-022-03109-4
- URN
-
urn:nbn:de:101:1-2022042618582605542213
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:22 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bazargani, Behnaz
- Noparast, Zahra
- Khedmat, Leila
- Fahimi, Daryoosh
- Esfahani, Seyed Taher
- Moghtaderi, Mastaneh
- Abbasi, Arash
- Afshin, Azadeh
- Mojtahedi, Sayed Yousef
- SpringerLink (Online service)
Ähnliche Objekte (12)
Rituximab for nephrotic syndrome in children
Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome
A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome
High detection rate for disease-causing variants in a cohort of 30 Iranian pediatric steroid resistant nephrotic syndrome cases
Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey
The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective
Low-dose rituximab is no less effective for nephrotic syndrome measured by 12-month outcome
Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases
Difficult Renal Pathological Classification in a Case of Pediatric Nephrotic Syndrome
Iranian Intellectuals’ Experience of Modern Science
Rituximab for nephrotic syndrome in children
Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome
A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome
High detection rate for disease-causing variants in a cohort of 30 Iranian pediatric steroid resistant nephrotic syndrome cases
Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey
The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective
Low-dose rituximab is no less effective for nephrotic syndrome measured by 12-month outcome
Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases
Difficult Renal Pathological Classification in a Case of Pediatric Nephrotic Syndrome
Iranian Intellectuals’ Experience of Modern Science
Rituximab for nephrotic syndrome in children
Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
Rituximab is not a “magic drug” in post-transplant recurrence of nephrotic syndrome
A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome
High detection rate for disease-causing variants in a cohort of 30 Iranian pediatric steroid resistant nephrotic syndrome cases
Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey
The efficacy and safety of rituximab in treating childhood nephrotic syndrome: an Italian perspective
Low-dose rituximab is no less effective for nephrotic syndrome measured by 12-month outcome
Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases
Difficult Renal Pathological Classification in a Case of Pediatric Nephrotic Syndrome